Biomea Fusion Inc (BMEA)
Healthcare
Biotechnology
1.20 $
-4.1%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Biomea Fusion Inc (BMEA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 93.3% of the shares are freely tradable; institutional investors hold 38.9%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
38.9%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
7.2%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
93.3%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
23.6%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
72Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| FMR Inc | 12.19 | 8,813,359 | +0.0 | 03/31/2026 |
| Vanguard Group Inc | 4.11 | 2,968,041 | +36.8 | 12/31/2025 |
| Vanguard Capital Management, LLC | 3.59 | 2,597,300 | +0.0 | 03/31/2026 |
| Aisling Capital Management LP | 2.83 | 2,048,757 | +0.0 | 03/31/2026 |
| Renaissance Technologies Corp | 1.82 | 1,312,798 | +174.3 | 03/31/2026 |
| Marshall Wace Asset Management Ltd | 1.66 | 1,198,551 | +3.3 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 5.44 | 3,934,088 | +0.1 | 04/30/2026 |
| Fidelity Growth Company Fund | 3.75 | 2,711,793 | +0.0 | 04/30/2026 |
| Vanguard Total Stock Mkt Idx Inv | 2.61 | 1,887,229 | +0.0 | 04/30/2026 |
| Fidelity Growth Company K6 | 1.26 | 910,113 | -0.3 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.